Finance

Lists
HBIO:NASDAQ
Harvard Bioscience Inc
8,27 US$
+0,36%
(+0,030) 1D
13 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HBIO...
Open
8,26 US$
High
8,49 US$
Low
8,19 US$
Mkt. cap
37,65 მლნ.
Avg. vol.
18,41 ათ.
Volume
0,00
52-wk high
9,40 US$
52-wk low
3,78 US$
EPS
-2,32 US$
Beta
1,50
Shares outstanding
4,55 მლნ.
No. of employees
328
Open
8,26 US$
High
8,49 US$
Low
8,19 US$
Mkt. cap
37,65 მლნ.
Avg. vol.
18,41 ათ.
Volume
0,00
52-wk high
9,40 US$
52-wk low
3,78 US$
EPS
-2,32 US$
Beta
1,50
Shares outstanding
4,55 მლნ.
No. of employees
328
News stories
From web sources and news partners
Profile
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company's brands include: Biochrom, BTX, CMA, Data Sciences International, Harvard Apparatus, HEKA, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems, Panlab, and Warner Instruments. The company has approximately 355 employees, with 216 of those in the USA, and its principal manufacturing facilities are in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany. Wikipedia
About Harvard Bioscience Inc
CEO-
Employees328
Founded1901
HeadquartersHolliston, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorHealth care
Analyst
Recommendation
Action
Price target
Projected
Date
Bruce Jackson
Benchmark Co.
Buy
Maintained
6,00 US$
-27,4%
03/16/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
20,59 მლნ.
23,74 მლნ.
20,76 მლნ.
22,73 მლნ.
Cost of goods sold
8,57 მლნ.
9,56 მლნ.
8,51 მლნ.
10,10 მლნ.
Cost of revenue
8,57 მლნ.
9,56 მლნ.
8,51 მლნ.
10,10 მლნ.
Research and development expenses
2,13 მლნ.
2,18 მლნ.
2,33 მლნ.
2,45 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,79 მლნ.
7,81 მლნ.
10,04 მლნ.
10,02 მლნ.
Operating expense
11,78 მლნ.
10,85 მლნ.
13,18 მლნ.
13,29 მლნ.
Total operating expenses
20,35 მლნ.
20,41 მლნ.
21,69 მლნ.
23,39 მლნ.
Operating income
245,00 ათ.
3,32 მლნ.
-939,00 ათ.
-660,00 ათ.
Other non operating income
-365,00 ათ.
-3,95 მლნ.
-405,00 ათ.
-
EBT including unusual items
-1,13 მლნ.
-3,20 მლნ.
-3,31 მლნ.
-2,90 მლნ.
EBT excluding unusual items
-1,09 მლნ.
-2,99 მლნ.
-3,07 მლნ.
-2,58 მლნ.
Income tax expense
97,00 ათ.
-357,00 ათ.
117,00 ათ.
14,00 ათ.
Effective tax rate
-8,55%
11,14%
-3,54%
-0,48%
Other operating expenses
-
-
-
-
Net income
-1,23 მლნ.
-2,85 მლნ.
-3,42 მლნ.
-2,91 მლნ.
Net profit margin
-5,98%
-11,99%
-16,50%
-12,80%
Earnings per share
-
-
-0,33
-0,14
Interest and investment income
-
-
-
-
Interest expense
-966,00 ათ.
-2,36 მლნ.
-1,73 მლნ.
-1,79 მლნ.
Net interest expenses
-966,00 ათ.
-2,36 მლნ.
-1,73 მლნ.
-1,79 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,57 მლნ.
4,68 მლნ.
411,00 ათ.
715,00 ათ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები